Showing 1 - 10 of 13
This paper explores the changing role of government involvement in health care financing policy outside the United States. It provides a review of the economics literature in this area to elucidate the implications of recent policy changes on efficiency, costs, and quality. Our review reveals...
Persistent link: https://www.econbiz.de/10011126077
The ability of the next US president to rein in spending on healthcare and improve the productivity of the healthcare system is largely going to determine the country’s fiscal future. That is one of the conclusions of the latest in a series of US Election Analyses , published by the Centre for...
Persistent link: https://www.econbiz.de/10011126302
To quantify the economic burden of maternal health care services on Indian households and examine the levels of expenditure incurred in public and private health care institutions at the national, state and community levels. Cross-sectional population data from the 2004 National Sample Survey...
Persistent link: https://www.econbiz.de/10011126350
Romania has one of the highest mortality rates in Europe for ischemic heart disease and, especially, for cerebrovascular disease. Taking into account the actual prevalence of cardiovascular diseases, an augmentation of the demand for specialized medical services is expected. As this paper...
Persistent link: https://www.econbiz.de/10011126421
We exploit lottery wins to investigate the effects of exogenous changes to individuals' income on health care demand in the United Kingdom. This strategy allows us to estimate lottery income elasticities for a range of health care services that are publicly and privately provided. The results...
Persistent link: https://www.econbiz.de/10011206865
Assessing the value of new medical technologies may require new approaches that take into account a more comprehensive set of parameters than the incremental cost/QALY. It is argued that MCDA can fulfil this role and has the potential to be methodologically superior to the currently used...
Persistent link: https://www.econbiz.de/10010884583
This paper investigates the determinants of the prices of branded prescription medicines across different regulatory settings and health care systems, taking into account their launch date, patent status, market dynamics and the regulatory context in which they diffuse. By using volume-weighted...
Persistent link: https://www.econbiz.de/10010884744
Persistent link: https://www.econbiz.de/10011071387
This study introduces a theoretical framework for the economics of preventative healthcare. Mathematical models are used to explain how the price and utilization of prevention change depending on demand, as well as factors such as the price of a cure, the probability of illness, the efficacy of...
Persistent link: https://www.econbiz.de/10010744804
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10010745148